{"id":13808,"date":"2024-09-05T15:11:54","date_gmt":"2024-09-05T22:11:54","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13808"},"modified":"2024-09-05T15:11:54","modified_gmt":"2024-09-05T22:11:54","slug":"new-zepbound-options-aim-to-increase-drug-accessibility","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/new-zepbound-options-aim-to-increase-drug-accessibility\/","title":{"rendered":"New Zepbound options aim to increase drug accessibility"},"content":{"rendered":"<section class=\"kc-elm kc-css-998009 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-790270 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-598838 kc_text_block\"><p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">In an effort to widen supply and improve access to its weight loss drug Zepbound for people who do not have insurance, Eli Lilly &amp; Co. has introduced a new version of the medication at half the price. The drug is now available in 2.5 mg and 5 mg single-dose vials through the manufacturer&#8217;s direct-to-consumer website, costing $399 and $549 per month, respectively.<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">\u00a0Full Story: <a href=\"https:\/\/www.cnbc.com\/2024\/08\/27\/zepbound-eli-lilly-releases-new-cheaper-form-of-weight-loss-drug.html\">CNBC<\/a> (8\/27)\u00a0\u00a0<\/span><\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p><span style=\"font-style: inherit;\">\u00a0<\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section><!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13808","post","type-post","status-publish","format-standard","hentry","category-diabetes-related-news"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13808"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13808\/revisions"}],"predecessor-version":[{"id":13809,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13808\/revisions\/13809"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}